Eleva's Drug Candidate to Be Examined for Use in COVID-19 Trea...
FREIBURG, Germany, June 3, 2020 /PRNewswire-AsiaNet/ -- Eleva, a manufacturer of superior biologics, is exploring the potential of one of its drug candidates for first-in-line therapy of COVID-19. The compound, factor H, is part of the complement system, which is believed to affect the severity of the ...
Authors: LATEST ASIANET NEWS RELEASES